This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Orexigen Therapeutics Inc (OREX)

NASDAQ: Health Care

Company Balance Sheet
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Assets
Cash and Equivalents 98.12M 78.33M 101.75M 24.93M
Receivables 0.00 0.00 0.00 0.00
Inventories 0.00 0.00 0.00 0.00
Other Current Assets 0.00 0.00 0.00 0.00
Total Current Assets 178.28M 138.89M 148.72M 94.87M
Property, Plant & Equipment, Gross 2.58M 1.96M 2.14M 2.28M
Accumulated Depreciation & Depletion 1.95M 1.88M 1.70M 1.38M
Property, Plant & Equipment, Net 630.00K 83.00K 439.00K 894.00K
Intangibles 0.00 0.00 0.00 0.00
Other Non-Current Assets 1.21M 177.00K 542.00K 1.08M
Total Non-Current Assets 1.84M 260.00K 981.00K 1.98M
Liabilities & Shareholder Equity
Total Assets 180.12M 139.15M 149.70M 96.85M
Accounts Payable 4.79M 3.81M 1.53M 3.11M
Short Term Debt 0.00 0.00 0.00 2.42M
Other Current Liabilities 0.00 0.00 0.00 0.00
Total Current Liabilities 22.85M 25.11M 7.71M 16.29M
Long Term Debt 80.03M 0.00 0.00 0.00
Deferred Income Taxes 0.00 0.00 0.00 0.00
Other Non-Current Liabilities 35.38M 38.57M 42.29M 46.77M
Minority Interest 0.00 0.00 0.00 0.00
Total Non-Current Liabilities 115.41M 38.57M 42.29M 46.77M
Total Liabilities 138.26M 63.68M 49.99M 63.06M
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 41.86M 75.47M 99.71M 33.79M
Common Par 105.00K 84.00K 61.00K 48.00K
Additional Paid In Capital 556.24M 512.17M 446.36M 352.40M
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings -514.48M -436.80M -346.71M -318.65M
Treasury Stock 0.00 0.00 0.00 0.00
Other Equity Adjustments -3.00K 15.00K -2.00K -9.00K
Total Capitalization 121.89M 75.47M 99.71M 33.79M
Total Equity 41.86M 75.47M 99.71M 33.79M
Total Liabilities & Stock Equity 180.12M 139.15M 149.70M 96.85M
Total Common Shares Outstanding 104.97M 84.41M 61.29M 47.77M
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 0.00 0.00 0.00 0.00
Basic Weighted Shares Outstanding 96.49M 70.74M 48.27M 47.38M
Diluted Weighted Shares Outstanding 96.49M 70.74M 48.27M 47.38M
Number of Employees 50 41 23 33
Number of Part-Time Employees 1 2 2 1
OREX News

OREX Orexigen Therapeutics Inc

Analysts Ratings for OREX

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 6 6 6 6
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
GET OREX ANALYST REPORT

Brokerage Partners

OREX Chatter

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Breakout Stocks

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs